CM Management LLC Sells 75,000 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

CM Management LLC lessened its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 37.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 125,000 shares of the pharmacy operator’s stock after selling 75,000 shares during the quarter. CM Management LLC’s holdings in Walgreens Boots Alliance were worth $1,166,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Charles Schwab Investment Management Inc. grew its position in shares of Walgreens Boots Alliance by 43.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after purchasing an additional 3,329,857 shares in the last quarter. Altrius Capital Management Inc increased its stake in Walgreens Boots Alliance by 76.6% during the 3rd quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator’s stock valued at $3,947,000 after purchasing an additional 190,996 shares in the last quarter. Swedbank AB raised its holdings in shares of Walgreens Boots Alliance by 45.3% during the fourth quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator’s stock valued at $5,559,000 after purchasing an additional 185,762 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Walgreens Boots Alliance by 23.4% in the 3rd quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator’s stock worth $3,050,000 after purchasing an additional 64,586 shares during the period. Finally, Sasco Capital Inc. CT increased its holdings in Walgreens Boots Alliance by 13.6% in the 3rd quarter. Sasco Capital Inc. CT now owns 1,041,440 shares of the pharmacy operator’s stock worth $9,331,000 after acquiring an additional 124,950 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA opened at $11.39 on Friday. The company has a market capitalization of $9.84 billion, a price-to-earnings ratio of -1.11, a PEG ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.05. The firm has a 50-day moving average of $10.64 and a two-hundred day moving average of $9.72. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period last year, the company posted $0.66 earnings per share. As a group, analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analyst Ratings Changes

WBA has been the topic of several recent analyst reports. Evercore ISI increased their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Royal Bank of Canada upped their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Truist Financial reduced their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Finally, Bank of America raised their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $11.54.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.